Back to Mitsubishi UFJ Asset Management Co., Ltd. Mitsubishi UFJ Asset Management Co., Ltd.

CRSPCRSP

Showing 8 of 31 quarters

Position history for Mitsubishi UFJ Asset Management Co., Ltd.Mitsubishi UFJ Asset Management Co., Ltd.'s holdings in CRISPR THERAPEUTICS AG

Yes. Mitsubishi UFJ Asset Management holds 5,194 shares of CRSP (Crispr Therapeutics), worth $283,281, as of its Q2 2026 13F filing. It increased the position by 315 shares (+6.5%) from Q1 2026. Mitsubishi UFJ Asset Management has held CRSP in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$283,281

Current Shares

5,194

Total Value Change

+$54,019

Total Shares Change

+314

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5,194
+6.5%
$283,2810.0%$54.54
25
2026-Q1
Increased
4,879
+6.6%
$232,0940.0%$47.57
25
2025-Q4
Decreased
4,576
-25.0%
$246,0520.0%$52.44
0
2025-Q3
Increased
6,103
+0.2%
$395,5350.0%$64.81
24
2025-Q2
Increased
6,091
+6.4%
$296,2660.0%$48.64
25
2025-Q1
Increased
5,725
+9.0%
$194,8220.0%$34.03
25
2024-Q4
Increased
5,252
+7.6%
$215,4370.0%$39.36
25
2024-Q3
Decreased
4,880
-8.5%
$229,2620.0%$46.98
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used